1995
-
A
Forty-Eight Week Study of Study Drug in Patients with Alzheimer's
Disease.
-
A
Twenty-Four Week Study of Study Drug in Patient with Dementia
Associated with Vascular Disease.
-
A
Multicenter, Open Label Trial Evaluating the Safety and Tolerability
of Study Drug in the Treatment of Elderly Subjects with Selected
Idiopathic and Organic Psychosis.
-
A
Randomized, Triple-Blind, Double Dummy, Placebo-Controlled,
Parallel Groups, Outpatient Study to Examine the Safety and
Efficacy of Study Drug for the Treatment of Acute Migraine
and Migraine Recurrence.
-
Study
Drug vs. Placebo in OCD Relapse Prevention.
back
to top
1987
| 1993 | 1994
| 1995 | 1996
| 1997 | 1998
| 1999
| 2000
| 2001 |
2002
|
2003 | 2004 | 2005 | 2006
home | about us | principal
investigator | clinical trials
| interest form | directions
| contact
